Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. NVDA
10. FDXF

Go back to Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial
(NASDAQ: CMND) Delayed: 2.38 -0.11 (4.42%)
Previous Close $2.49    52 Week High $ 
Open $2.44    52 Week Low $ 
Day High $2.50    P/E N/A 
Day Low $2.36    EPS $ 
Volume 39,282